What's Going On With Reunion Neuroscience Stock Today
Portfolio Pulse from Nabaparna Bhattacharya
Reunion Neuroscience Inc. (NASDAQ:REUN) has signed a take-private deal with MPM BioImpact, where MPM will acquire Reunion for $13.1 million. Reunion will receive $1.12 in cash for each share held. The deal represents a 43.1% premium over the trailing 30-trading-day volume weighted average price.
June 02, 2023 | 2:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Reunion Neuroscience's stock is likely to be positively impacted by the take-private deal with MPM BioImpact, as shareholders will receive a 43.1% premium over the trailing 30-trading-day volume weighted average price.
The take-private deal with MPM BioImpact is a positive development for Reunion Neuroscience's stock, as it offers a significant premium to shareholders. This is likely to result in increased demand for the stock, driving the price higher in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100